Company Overview and News

0
Boss Resources enhances gold resource at West African prospects

2018-07-13 proactiveinvestors.com.au
Boss Resources Ltd (ASX:BOE) has hit near-surface and deeper gold intersections during drilling at three prospects within its Golden Hill property in Burkina Faso.
TGZ BOE TGZ

0
Teranga Gold’s Golden Hill Exploration Update Includes Strong Grades and Excellent Correlation at Multiple Prospects and a New Discovery at Peksou North

2018-07-12 globenewswire
TORONTO, July 12, 2018 (GLOBE NEWSWIRE) -- Teranga Gold Corporation ("Teranga" or the "Company") (TSX:TGZ) (OTCQX:TGCDF) is pleased to announce that its most recent diamond drill program on the Golden Hill property in Burkina Faso, West Africa has returned near surface and deeper gold intersections that will enhance resources at a number of advanced prospects. In addition, the recent drilling evaluation program identified a new near-surface discovery at Peksou North, one of 9 prospects drilled at Golden Hill over the past 18 months.
TGZ BOE TGZ

15
Uranium Mining: The Inflection On The Horizon

2018-06-18 seekingalpha
After a 10-year-old downtrend, uranium price may finally see light at the end of the tunnel, with major producers cutting production.
PDN PALAY PALAF BOE PDN URG CCJ

0
Boss Resources' 49% interest in Burkina Faso gold projects paying dividends

2018-04-17 proactiveinvestors.com.au
Boss holds a 49% interest in a joint venture with Teranga over the Golden Hill and Gourma gold projects in Burkina Faso, West Africa.
BOE

2
Teranga Gold Reports High-Grade Gold from Phase 2 Drilling at Golden Hill’s C-Zone Prospect

2018-04-16 globenewswire
TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Teranga Gold Corporation ("Teranga" or the "Company") (TSX:TGZ) (OTCQX:TGCDF) is pleased to announce that its phase 2 diamond drill program at the C-Zone prospect on the Golden Hill property in Burkina Faso, West Africa has returned near surface and deeper high-grade gold intersections.
TGZ BOE TGZ

0
Boss raises $8m

2018-03-26 businessnews.com.au
Boss Resources has raised $8 million through a share placement and will use the proceeds to advance a definitive feasibility study at the company’s Honeymoon uranium project in South Australia.
BOE

2
Boss Resources’ earn-in partner hits high-grade gold in West Africa

2018-03-23 proactiveinvestors.com.au
Boss Resources Ltd (ASX:BOE) earn-in partner Teranga Gold Corporation (TSX:TGZ) has received high-grade gold hits from drilling at Golden Hill Gold Project in West Africa.
TGZ BOE TGZ

2
Teranga’s Golden Hill Drill Program Intersects High-Grade Gold and Expands Mineralized Zones at Peksou and Ma Prospects

2018-03-22 globenewswire
Results include 6.78 g/t gold over 11 metres and 2.09 g/t gold over 27 metres at Peksou, and 6.46 g/t gold over 5 metres and 6.39 g/t gold over 6 metres at Ma North
TGZ BOE TGZ

0
Public fallout

2018-03-14 australianmining.com.au
Australia has always been famously shy of nuclear power and construction of plants is prohibited to this day.
BOE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:BOE / BOSS RESOURCES LIMITED on message board site Silicon Investor.

Boeing keeps setting new highs! When will it split? BA: Boeing Company
PKS Buyout of BA Six Flags buys Boeing - Thoughts? Boeing - Crisis?, What Crisis?!
Boeing, McDonnell Douglas and Fields Aircraft Spares Boeing and Fields Aircraft Spares (FASI)